Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Stockholders' Deficit - Warrant Activity (Details)

v3.7.0.1
Note 7 - Stockholders' Deficit - Warrant Activity (Details) - $ / shares
 9 Months Ended 12 Months Ended
Mar. 31, 2017
Jun. 30, 2016
Outstanding and exercisable, number of warrants, beginning balance (in shares) 28,040,096  
Outstanding and exercisable, weighted average exercise price per warrant, beginning balance (in dollars per share) $ 0.20  
Exchanged, number of warrants (in shares) (2,714,197)  
Exchanged, weighted average exercise price per warrant (in dollars per share) $ 0.14  
Outstanding and exercisable, number of warrants, ending balance (in shares) 25,325,900 28,040,096
Outstanding and exercisable, weighted average exercise price per warrant, ending balance (in dollars per share) $ 0.21 $ 0.20
Minimum [Member]    
Outstanding and exercisable, remaining contract term, beginning balance (Year) 131 days 142 days
Maximum [Member]    
Outstanding and exercisable, remaining contract term, beginning balance (Year) 1 year 255 days 2 years 182 days